Specify a stock or a cryptocurrency in the search bar to get a summary
Qingdao Vland Biotech Co Ltd
603739Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was incorporated in 2005 and is headquartered in Qingdao, China. Address: No. 596-1, Jiushui East Road, Qingdao, China, 266100
Analytics
WallStreet Target Price
95.48 CNYP/E ratio
60.6923Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603739
Dividend Analytics 603739
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
39 %Dividend History 603739
Stock Valuation 603739
Financials 603739
Results | 2019 | Dynamics |